Found: 23
Select item for more details and to access through your institution.
Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1159, doi. 10.1007/s00277-023-05108-6
- By:
- Publication type:
- Article
(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
P14.54 Primary central nervous system lymphoma of the spinal cord: a LOC network cohort study.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
P14.48 Extracerebral relapses of primary CNS lymphoma (PCNSL): a LOC network retrospective study.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii47, doi. 10.1093/neuonc/noab180.161
- By:
- Publication type:
- Article
P03.04 Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive prognosis. Study of a monocentric cohort of 27 patients.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
P14.73 Toxicity and outcomes of reduced-dose whole brain radiotherapy as consolidation treatment for patients with CNS lymphoma in real life setting.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii84, doi. 10.1093/neuonc/noz126.308
- By:
- Publication type:
- Article
P14.45 Primary diffuse large B-cell CNS lymphoma over 80 years: an analysis of 110 patients from the french Oculo-Cerebral Lymphoma (LOC) network.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii77, doi. 10.1093/neuonc/noz126.280
- By:
- Publication type:
- Article
P14.118 Carboxypeptidase G2 (CPG2) rescue after high dose methotrexate (hdMTX) chemotherapy for Primary CNS Lymphoma (PCNSL). A French LOC network study.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii96, doi. 10.1093/neuonc/noz126.353
- By:
- Publication type:
- Article
P05.87 Hemoglobin level is a relevant prognostic marker of overall survival in primary central nervous system lymphoma: a retrospective study on 160 PCNSL.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii323, doi. 10.1093/neuonc/noy139.413
- By:
- Publication type:
- Article
P01.041 Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii238, doi. 10.1093/neuonc/noy139.083
- By:
- Publication type:
- Article
P11.04 MALT CNS LYMPHOMAS: A MONOCENTRIC EXPERIENCE.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii60, doi. 10.1093/neuonc/nou174.227
- By:
- Publication type:
- Article
P11.03 OPTIC NERVE INFILTRATION OF PRIMARY CNS LYMPHOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii59, doi. 10.1093/neuonc/nou174.226
- By:
- Publication type:
- Article
P11.05 LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL).
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii60, doi. 10.1093/neuonc/nou174.228
- By:
- Publication type:
- Article
P17.08 RENAL THROMBOTIC MICROANGIOPATHY INDUCED BY BEVACIZUMAB IN HIGH GRADE GLIOMA PATIENTS - ABOUT SIX CASES.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii88, doi. 10.1093/neuonc/nou174.338
- By:
- Publication type:
- Article
Neurotoxicity in patients with CNS lymphomas treated with CAR‐T cell therapy. A LOC network study.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 536, doi. 10.1002/hon.3164_398
- By:
- Publication type:
- Article
COMBINATION OF RITUXIMAB‐LENALIDOMIDE‐IBRUTINIB IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA: A COHORT STUDY OF THE LOC NETWORK.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.73_2880
- By:
- Publication type:
- Article
CAR‐T CELL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): THE EXPERIENCE OF THE FRENCH NETWORK FOR OCULO‐CEREBRAL LYMPHOMAS (LOC)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.74_2880
- By:
- Publication type:
- Article
TEMOZOLOMIDE IN RELAPSE/REFRACTORY PRIMARY VITREO‐RETINAL LYMPHOMA (R/R PVRL): A SIMPLE, CHEAP, EFFECTIVE AND WELL TOLERATED TREATMENT. RESULT OF THE LARGEST STUDY ON R/R PVRL, FROM THE LOC NETWORK.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 269, doi. 10.1002/hon.79_2630
- By:
- Publication type:
- Article
TEMOZOLOMIDE IN RELAPSE/REFRACTORY PRIMARY VITREO‐RETINAL LYMPHOMA (R/R PVRL): A SIMPLE, CHEAP, EFFECTIVE AND WELL TOLERATED TREATMENT. RESULT OF THE LARGEST STUDY ON R/R PVRL, FROM THE LOC NETWORK.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 269, doi. 10.1002/hon.79_2630
- By:
- Publication type:
- Article
IBRUTINIB IN RELAPSE OR REFRACTORY PRIMARY CNS AND VITREO-RETINAL LYMPHOMA. RESULTS OF THE PRIMARY END-POINT OF THE ILOC PHASE II STUDY FROM THE LYSA AND THE FRENCH LOC NETWORK.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 72, doi. 10.1002/hon.2437_59
- By:
- Publication type:
- Article
Prevalence of hepatitis B virus in primary central nervous system lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 115, n. 2, p. 261, doi. 10.1007/s11060-013-1224-1
- By:
- Publication type:
- Article